Suppression_of_chronic_myelogenous_leukemia_colony_growth_by_interleukin-1_(IL-1)_receptor_antagonist_and_soluble_IL-1_receptors:_a_novel_application_for_inhibitors_of_IL-1_activity._In_this_study,_we_investigated_the_role_of_interleukin-1_beta_(IL-1_beta)_in_the_malignant_evolution_of_chronic_myelogenous_leukemia_(CML)_and_the_functional_activity_of_IL-1_inhibitors._Bone_marrow_(BM)_and_peripheral_blood_(PB)_low-density_cells_from_38_CML_patients_were_studied_in_the_colony-forming_unit-granulocyte,_erythrocyte,_monocyte,_megakaryocyte_colony_culture_assay._Samples_from_patients_with_early_stage,_interferon-alpha_(IFN)-sensitive_disease_formed_hematopoietic_colonies_in_the_presence_of_fetal_calf_serum_(FCS),_erythropoietin_(Epo),_and_one_of_the_following:_granulocyte-macrophage_colony-stimulating_factor_(10_ng/mL),_IL-3_(15_ng/mL),_both,_or_phytohemagglutinin-conditioned_medium._The_addition_of_IL-1_beta_augmented_IFN-sensitive_CML_colony_growth_in_a_dose-dependent_manner_at_concentrations_of_10_to_100_U/mL._In_sharp_contrast,_addition_of_the_above_growth_factors_did_not_augment_the_colony_growth-promoting_effect_of_FCS_and_Epo_in_samples_from_IFN-resistant_patients;_further,_adherent_cell_fractionation_or_T-lymphocyte_depletion_attenuated_the_"autonomous"_colony_growth._Lysates_of_2.5_x_10(7)_low-density_cells_from_each_of_six_IFN-resistant_and_six_IFN-sensitive_CML_patients_and_three_normal_volunteers_were_tested_for_intrinsic_IL-1_beta_content_in_an_enzyme-linked_immunosorbent_assay_and_yielded_a_mean_of_610_pg,_54.6_pg,_and_49.4_pg_of_IL-1_beta,_respectively_(P_less_than_.045)._Interestingly,_both_soluble_IL-1_receptors_(sIL-1R)_and_IL-1_receptor_antagonist_(IL-1RA)_at_concentrations_of_5_to_100_ng/mL_(sIL-1R)_and_10_to_500_ng/mL_(IL-1RA)_inhibited_CML_colony_growth_in_a_dose-dependent_fashion,_with_maximal_inhibition_of_64%_and_65%,_respectively._A_similar_effect_was_noted_with_the_use_of_anti-IL-1_beta_neutralizing_antibodies._These_data_implicate_IL-1_beta_in_CML_disease_progression_and_suggest_that_the_inhibitory_effects_of_molecules_such_as_sIL-1R_and_IL-1RA_could_conceivably_be_the_basis_of_a_novel_therapeutic_strategy_against_this_disorder.